Clinical Trial

Cannabis Reduction and Functional Outcomes

Recruiting
View on ClinicalTrials.gov →
Summary
This study evaluates the effects of cannabis use reduction among adults diagnosed with cannabis use disorder (CUD). Participants will undergo an 8-week intervention combining motivational interviewing, computerized cognitive behavioral therapy (CBT4CBT), and financial incentives for reduction in urinary cannabinoids. The study aims to assess improvements in cannabis-related problems, sleep, cognitive performance, CUD severity, and quality of life.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-16.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT07218471
Lead Sponsor Medical University of South Carolina
Collaborators: National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)
Conditions Cannabis Use Disorder
Enrollment 176 participants
Start Date 2026-03-13
Primary Completion 2029-09-15 (estimated)
Study Completion 2030-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-19